Real-time enrollment status for this myelodysplastic syndromes clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 4:41 AM UTC
| NCT Number | NCT06297941 |
| Recruiting Status | Recruiting |
| Condition | Myelodysplastic Syndromes |
| Phase | PHASE1 |
| Target Enrollment | 100 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Remix Therapeutics |
| Last Updated on CT.gov | April 23, 2025 (Apr 23, 2025) |
As of July 20, 2026: Clinical trial NCT06297941 is currently recruiting participants. This phase1 study for myelodysplastic syndromes is actively seeking new participants at 5 locations across the United States. The study is sponsored by Remix Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06297941 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06297941 was last updated Apr 23, 2025 (April 23, 2025). HelloStudys verifies this status automatically.